The company is a government licensed manufacturer of clinical grade stem cells and is approved by the FDA for clinical trials in ischemic stroke, cutaneous photoaging and STEMI. Stemedica is currently developing regulatory pathways for a number of other medical indications using adult allogeneic stem cells.